CLASS III Drug recall · Reported 6 Apr 2022 · FDA Enforcement Report

Clotrimazole and Betamethasone Dipropionate Cream recalled

Taro Pharmaceuticals U is recalling Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05% tubes, distributed in New York. The recall was initiated on 25 Feb 2022 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: AC33883, Exp. Date June 2023
NDC51672-4048
Quantity recalled768 tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0727-2022
FDA event ID
89678
Recalling firm
Taro Pharmaceuticals U, Hawthorne, NY
Manufacturer
Sun Pharmaceutical Industries, Inc.
Classification
Class III
Status
Terminated
Recall initiated
25 Feb 2022
FDA classified
29 Mar 2022
Reported
6 Apr 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

25 Feb 2022Recall initiated by company
29 Mar 2022Classified by FDA+32 days
6 Apr 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropionate assay of a stability sample

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4048-1

Where it was distributed

Product was distributed to one retail consignee in NY.

New York

Questions about this recall

Why was it recalled?

Failed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropionate assay of a stability sample

Which lots are affected?

Lot #: AC33883, Exp. Date June 2023

Where was it sold?

Product was distributed to one retail consignee in NY.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Taro Pharmaceuticals U

All 36

Other Clotrimazole recalls

All 12